Michael Migden, M., Carmen Loquai, M., Caroline Robert, M., Jean-François Baurain, M., Nicholas Squittieri, M., Ramon Arntz, D., . . . Brigitte Dréno, M. (2023). Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks. Elsevier.
Chicago Style (17th ed.) CitationMichael Migden, MD, MD Carmen Loquai, MD Caroline Robert, MD Jean-François Baurain, MD Nicholas Squittieri, Dr Ramon Arntz, BSc Jörg Dierlamm, and MD Brigitte Dréno. Sonidegib Improved Quality of Life in Patients with Advanced Basal Cell Carcinoma: Results from the Phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment Trial Through 73 weeks. Elsevier, 2023.
MLA (9th ed.) CitationMichael Migden, MD, et al. Sonidegib Improved Quality of Life in Patients with Advanced Basal Cell Carcinoma: Results from the Phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment Trial Through 73 weeks. Elsevier, 2023.